Gastrointestinal amyloidosis: an often unexpected finding with systemic implications
Catherine E. Hagen(Massachusetts General Hospital), Ellen D. McPhail(Mayo Clinic), Linda N. Dao(Mayo Clinic), April Chiu(Mayo Clinic), Surendra Dasari(Mayo Clinic in Arizona), Paul J. Kurtin(Mayo Clinic), Taxiarchis Kourelis(Mayo Clinic in Arizona), Eli Muchtar(Mayo Clinic), Joanna Dalland(Mayo Clinic), Jason D. Theis(Mayo Clinic), Karen L. Rech(Mayo Clinic in Arizona), Matthew T. Howard(Mayo Clinic), Angela Dispenzieri(Mayo Clinic), Julie A. Vrana(University of Gothenburg), Morie A. Gertz(Medical University of South Carolina)
Cited by 16
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k